| Sl. No | Name of Department | Project Name | Period of Study | Funding Agency |
|---|---|---|---|---|
| 1 | FORENSIC MEDICINE & TOXICOLOGY | Serum Phospholipase A2, Hyaluronidase , Metalloprotease, Serine Protease and 3FT- Three-finger Toxin as biomarkers for diagnosis and confirmation of snake envenomation: A hospital based study | Starting Year-2021 Proposed Year of completion-2023 | ICMR, New Delhi |
| 2 | BIOCHEMISTRY | Study to Determine the Therapeutic Potential of Natural products, Aegel marmelos (L.), Bael in the treatment of Covid-19 patients | Starting Year- Nov 2020 Proposed Year of completion-2023 | Health & Family Welfare Department, Govt of Odisha. |
| 3 | CARDIOLOGY | NATIONAL HEART FAILURE REGISTRY | 3 years. Started 18.09.2018 | ICMR |
| 4 | CLINICAL HEMATOLOGY | WFH Hemophilia Treatment Center Twinning Programme Sociological impact and Tribal Health: A study on Epidemiological Diversity of Thalassaemia mutation among Tribes and Impact of Sociological Influence |
2 Years (Upto 2021) 5Years (Starting year 2017) |
WFH(World Federation of Hemophilia) Ministry of Science and Technology, Govt. of India |
| 5 | MICROBIOLOGY | Development & Optimization of a novel point of care Assay for human leptospirosis | 3 Years (2021-24) | DHR |
| 6 | OBSTETRICS & GYNAECOLOGY | TITLE: NATIONAL STRATEGY OF COVID-19 INFECTION ON PREGNANCY AND THEIR NEONATES TITLE: MATERNAL NEAR MISS REVIEW TITLE: The WHO ACTION (Antenatal Corticos Teroids for Improving Outcomes in preterm Newborns) Trials -ACTION I AND ACTION II TITLE: SCOPE – Standardization of COVID in Pregnancy |
Starting Year-June 2020 Proposed Year of completion-2023 Starting Year-November – 2020 Proposed Year of completion-2023 Starting Year-November – 2018 Year of completion-2020 Starting Year-April 2020 Proposed Year of completion December-2020 |
ICMR ICMR WHO WHO Country Office |
| 7 | PULMONARY MEDICINE |
A Phase III, Randomized, Double-blind, Placebocontrolled Trial to Evaluate the Efficacy and Safety of VPM1002 and Immuvac Vaccines in Preventing Tuberculosis (TB) in Healthy Household Contacts of Newly Diagnosed Sputum Positive Pulmonary TB Patients An Open-Label, Non-Randomized, Two-Stage, Dose-Finding Study Of Verapamil Tablet Formulation In Adult Tuberculosis Patients In Continuation Phase Of Anti-Tuberculosis Treatment |
38 months (03.20.2018 to 15.11.2020) 38 months (03.20.2018 to 15.11.2020) |
ICMR ICMR, New Delhi |
| 8 | RHEUMATOLOGY |
Role of vitamin D3 in SLE:A double blind randomized controlled trial Duration Multi-institutional network programme on SLE: understanding the diversity of SLE |
2017 to 2020 2018 to 2023 |
ICMR DBT |
| 9 |
COMBINED MULTI-DEPARTMENTAL PROJECTS BIOCHEMISTRY, OBSTETRICS & GYNAECOLOGY, HAEMATOLOGY BIOCHEMISTRY, OBSTETRICS & GYNAECOLOGY, HAEMATOLOGY COMMUNITY MEDICINE & PLASTIC SURGERY NEUROLOGY & GENERAL MEDICINE NEUROLOGY & GENERAL MEDICINE |
Detection of Genetic mutation in Chorionic Villous Sample (CVS) for prenatal diagnosis of Thalassemia. Haemoglobinopathy detection from cord blood. Situational analysis of burn injury under the guidance of AIIMS, Delhi. DEVELOPMENT OF POPULATION BASED STROKE REGISTRY (PBSR) HTA OF NATIONAL STROKE CARE REGISTRY PROGRAMME DEVELOPMENT OF HOSPITAL BASED STROKE REGISTRIES IN DIFFERENT REGIONS OF INDIA |
Starting Year-December – 2020 Proposed Year of completion -2025 Starting Year-December – 2020 Proposed Year of completion -2025 2019 to 2021 Started-01.03.2017 Proposed Year of completion-2025 Starting Year-December 2018 Proposed Year of completion-2023 |
NHM in collaboration with CMC Vellore NHM in collaboration with CMC Vellore Ministry of H & FW, Govt. of India. Department of Health Research (DHR), ICMR. Department of Health Research (DHR), ICMR. |
| PROJECT NAME | FUNDING AGENCY | FUNDS RECEIVED | FUNDS RECEIVED | FUNDS RECEIVED |
|---|---|---|---|---|
| 2017-18 | 2018-19 | 2019-20 | ||
| PBSR (Neurology and Med) | ICMR | 1943500 | 300000 | 941071 |
| HBSR (Neurology and Med) | ICMR | 500000 | ||
| DIABETES MELLITUS YOUNG (Med) | ICMR | 1059704 | 1008016 | 386407 |
| INDIA B STUDY (Med) | ICMR | 4958000 | ||
| HUMAN REPRODUCTION RESOURCE CENTER (OBG) | ICMR | 822640 | 1476919 | 2602887 |
| 822641 | 1260916 | |||
| 1586987 | ||||
| VIT-D RHEUMATOLOGY | ICMR | 337284 | 509575 | 197895 |
| ACTION TRIAL (O & G) | WHO | 636257 | 760000 | |
| 791867 | 636257 | |||
| 236257 | ||||
| CHAMPION TRIAL (O & G) | WHO | 160650 | 180900 | |
| 774987 | 39760 | |||
| Sociologic impact and Tribal Health (Haematology) | DST | 438000 | ||
| Hemophilia Treatment Centre Twinning Programme (Haematology) | WFH | 140000 | ||
| TOTAL | 8646393 | 6344210 | 11218774 |
